2,4-pyridinedicarboxylic acid has been researched along with Kahler Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Athanasou, N; Badock, V; Brennan, PE; Brown, J; Burgess-Brown, N; Egner, U; Gileadi, C; Hookway, ES; Johansson, C; Kopec, J; LaThangue, NB; Munro, S; Nowak, RP; Nuzzi, A; Oppermann, U; Philpott, M; Prinjha, R; Steuber, H; Strain-Damerell, C; Szykowska, A; Tumber, A; Velupillai, S; Westaway, S; Wu, N | 1 |
1 other study(ies) available for 2,4-pyridinedicarboxylic acid and Kahler Disease
Article | Year |
---|---|
Structural analysis of human KDM5B guides histone demethylase inhibitor development.
Topics: Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Models, Molecular; Multiple Myeloma; Nuclear Proteins; Protein Conformation; Repressor Proteins; Structure-Activity Relationship | 2016 |